Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
Experiment start date - 11 October 1993; Experiment end date - 05 November 1993; Study completion date - 10 December 1993.
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1993
Report date:
1993

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
Deviations:
no
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
Data from a reliable in vivo test conducted before the enforcement of Commission Regulation (EU) 640/2012 of 06 July 2012 amending, for the purpose of its adaptation to technical progress, Regulation (EC) No 440/2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) are available.

Test material

Constituent 1
Chemical structure
Reference substance name:
3(or5)-[[4-[benzylmethylamino]phenyl]azo]-1,2(or1,4)-dimethyl-1H-1,2,4-triazolium bromide
EC Number:
289-660-0
EC Name:
3(or5)-[[4-[benzylmethylamino]phenyl]azo]-1,2(or1,4)-dimethyl-1H-1,2,4-triazolium bromide
Cas Number:
89959-98-8
Molecular formula:
C18H21N6.Br
IUPAC Name:
Reaction mass of 3-[{4-[Benzyl(methyl)amino]phenyl}diazenyl]-1,4-dimethyl-4H-1,2,4-triazol-1-ium bromide and 5-[{4-[Benzyl(methyl)amino]phenyl}diazenyl]-1,4-dimethyl-4H-1,2,4-triazol-1-ium bromide
Specific details on test material used for the study:
- Test Article: FAT 31016/P
- Additional specification: Maxilonrot GRL BR,ro trocken
- Batch No.: 414154.32
- Contents/Purity: 95 %
- Physical properties: solid; red-brown powder
- Storage conditions: room temperature
- Validity: July, 1998
- Test article received: September 1, 1993

In vivo test system

Test animals

Species:
guinea pig
Strain:
other: Pirbright White Strain (Tif: DHP)
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: CIBA-GEIGY Limited, Animal Production, 4332 Stein / Switzerland
- Weight at study initiation: 327 to 391 g
- Housing: individually in Macrolon cages
- Diet: standard guinea pig pellets - NAFAG No. 845, Gossau SG; ad libitum
- Water: ad libitum
- Acclimation period: 5 days

ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3 °C
- Humidity: 30 to 70 %
- Photoperiod: 12 hours light cycle day
- IN-LIFE DATES: From: October 11, 1993 To: November 5, 1993

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal
Vehicle:
physiological saline
Concentration / amount:
5 %
Day(s)/duration:
Day 0
Adequacy of induction:
other: this concentration was well tolerated when injected intradermally
Route:
epicutaneous, occlusive
Vehicle:
other: vaseline
Concentration / amount:
50 %
Day(s)/duration:
Day 8
Adequacy of induction:
non-irritant substance, but skin pre-treated with 10% SDS
Challenge
No.:
#1
Route:
epicutaneous, occlusive
Vehicle:
other: vaseline
Concentration / amount:
50 %
Day(s)/duration:
Day 22
Adequacy of challenge:
highest non-irritant concentration
No. of animals per dose:
10 males and 10 females in the test groups
5 males and 5 females in the control group
Details on study design:
RANGE FINDING TESTS:

MAIN STUDY
A. INDUCTION EXPOSURE - Intradermal
- No. of exposures: 1
- Site: neck
- Frequency of applications: once only
- Concentrations: 5 %

B. INDUCTION EXPOSURE - Epidermal
- No. of exposures: 1
- Site: neck
- Frequency of applications: once only
- Concentrations: 50 %
- Exposure period: 48 hours

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: Day 22
- Exposure period: 24 hours
- Site: flanks
- Concentrations: 50 %
- Evaluation (hr after challenge): 24 and 48 hours after removing the dressings
Positive control substance(s):
yes
Remarks:
2-Mercaptobenzothiazole puriss

Results and discussion

Positive control results:
90 % of the exposed animals exhibited positive reactions.

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
5 %: intradermal induction, 50 %: epidermal induction, 50 %: epidermal challenge
No. with + reactions:
20
Total no. in group:
20
Remarks on result:
positive indication of skin sensitisation
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
5 %: intradermal induction, 50 %: epidermal induction, 50 %: epidermal challenge
No. with + reactions:
20
Total no. in group:
20
Remarks on result:
positive indication of skin sensitisation
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
no indication of skin sensitisation
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
no indication of skin sensitisation
Reading:
1st reading
Hours after challenge:
24
Group:
positive control
Dose level:
5 % Intradermal induction; 50 % Epidermal induction; 30 % Epidermal challenge.
No. with + reactions:
9
Total no. in group:
10
Remarks on result:
positive indication of skin sensitisation
Reading:
2nd reading
Hours after challenge:
48
Group:
positive control
Dose level:
5 % Intradermal induction; 50 % Epidermal induction; 30 % Epidermal challenge.
No. with + reactions:
9
Total no. in group:
10
Remarks on result:
positive indication of skin sensitisation

Any other information on results incl. tables

Under the experimental conditions employed, 100 % of the animals of the test group showed skin reactions 24 and 48 hours after removing the dressings.

Applicant's summary and conclusion

Interpretation of results:
Category 1B (indication of skin sensitising potential) based on GHS criteria
Conclusions:
FAT 31016/P was found to have strong sensitisation potential in the Guinea Pig Maximisation Test.
Executive summary:

A sensitisation test in albino guinea pigs was performed to determine the contact allergenic potency of FAT 31016/P. This test was based on the OECD Guideline No. 406, adopted May 12, 1981, adapted July 17, 1992, by the OECD council, and on Annex V, Part B of Council Directive 67/548/EEC (Commission Directive 92/69/EEC of July 31, 1992). The test was performed on 10 male and 10 female guinea pigs in the test group and 5 males and 5 females in the control group, respectively, initially weighing between 327 to 391 g. The test group animals were given test substance at 5 % (in physiological saline) during the intradermal induction phase, while exposed to 10 % SDS + 50 % test substance (in vaseline) at the epidermal induction phase. The test as well as control animals were then challenged with a epidermal application of the test substance at 50 % concentration (in vaseline). Under the experimental conditions employed, 100 % (20/20) of the animals of the test group showed skin reactions 24 and 48 hours after removing the dressings. Hence, FAT 31016/P was concluded to have strong sensitisation potential in the guinea pig maximisation test.